Former Chief Financial Officer · MAXCYTE, INC. (MXCT)

Amanda Murphy

A named executive officer of MAXCYTE in every fiscal year CompBrief holds from FY2020 to FY2021. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2021

$830,622

Salary $400,000Stock awards $0

FY2020: $2,778,295

3rd of 3 named executive officers at Maxcyte by FY2021 total.

3 named officers on file for MAXCYTE, FY2021

Amanda Murphy’s pay file — $29

  • 2 fiscal years of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how MAXCYTE’s whole pay program stands against its peers

  • MAXCYTE’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on MXCT→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed May 26, 2022 (DEF 14A).

Free

Get Amanda Murphy’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Amanda Murphy compensation by year

MAXCYTE Summary Compensation Table · all 2 fiscal years held
In US dollars, as MAXCYTE reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2020FY2021
Salary$125,758$400,000
Bonus$0$0
Stock awards$0$0
Option awards$2,425,826$99,360
Non-equity incentive$222,466$316,000
Pension and deferred compensation$0$0
All other$4,245$15,262
Total$2,778,295$830,622

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: MAXCYTE, INC. DEF 14A filed May 26, 2022, accession 0001140361-22-020805, and prior-year filings.

How this page was built: the MAXCYTE, INC. filed document, accession 0001140361-22-020805. Every figure is read from that document and cited to the page and table it appears in. Filed May 26, 2022.

$2.8M
$831K
FY20
FY21
SalaryNon-equity incentiveOption awardsAll other

Equity holdings

unvested awards at FY2021 year-end
TypeUnvested unitsValue at year-endExercise price
Option38,136—$14.46
Option670,833—$4.29
Option10,000—$16.63
Option142,000—$7.12

Per the Outstanding Equity Awards at Fiscal Year-End table in MAXCYTE, INC.'s FY2021 proxy; value at the fiscal year-end close, as the company printed it.

MAXCYTE’s named executive officers, FY2021

as the company reported each
Named executive officerRoleFY2021 total
Doug DoerflerPresident, Chief Executive Officer and Director$2,036,924
Ron HoltzChief Financial Officer$948,332
Amanda Murphy · this pageFormer Chief Financial Officer$830,622

The full MAXCYTE compensation record

free company brief

This page is one person within MAXCYTE's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are MAXCYTE's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Amanda Murphy's compensation dossier · One-time report. No refunds.